Active ingredient: Rufinamide 200 mg, 400 mg; scored tabs. Indication: Adjunctive treatment of seizures in Lennox-Gastaut syndrome (LGS). Pharmacology: LGS is a seizure disorder characterized by ...

More than 3.4 million people in the United States have epilepsy, so it is a relatively common diagnosis. In fact, it is the fourth-most common neurologic condition in the world. November is National ...

A seizure occurs when there is abnormal electrical activity in the brain. There are different types of seizures depending on where and how much brain activity is affected. If someone is seizing make ...

ALBANY, N.Y. (NEWS10) – Epilepsy is the fourth most common neurological disorder in the United States and can impact women and men. An estimated 3.4 million people in the U.S. have epilepsy, but there ...

At ten months old, Cole started suffering from atonic seizures. He would wear a helmet to protect himself from the condition that causes him to fall without warning. Aliyah Walker, 8, had the seizures ...

More than 3.4 million people in the US and 65 million people worldwide have epilepsy, a neurological disorder that affects the nervous system and causes seizures. One in 26 people will develop ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. In 2020, Aaron Pura was training at the police academy in ...

Adding cannabidiol (CBD) to antiepileptic drug (AED) therapy significantly reduces the frequency of drop seizures in patients with Lennox-Gastaut syndrome (LGS), results of a phase 3 ...